Correction: Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis

Affiliations

• ¹ UQ Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia.
• ² Paediatric Intensive Care Unit, Queensland Children's Hospital, South Brisbane, QLD, Australia.
• ³ Herston Infectious Disease Institute, Metro North, QLD Health, Herston, QLD, Australia.
• ⁴ Centre for Health Services Research, The University of Queensland, Brisbane, Australia.
• ⁵ Intensive Care Unit, Princess Alexandra Hospital, Brisbane, QLD, Australia.
• ⁶ Adult Intensive Care Services and Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.
• ⁷ Department of Infectious Diseases, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
• ⁸ Department of Chemical Pathology, Pathology Queensland, Brisbane, QLD, Australia.
• ⁹ Faculty of Biomedical Science, University of Queensland, Brisbane, QLD, Australia.
• ¹⁰ Optimum Dosing Strategies, Bloomingdale, NJ, 07403, USA.
• ¹¹ Department of Pharmacy, Saint Clare's Health, Denville, NJ, 07834, USA.
• ¹² ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
• ¹³ Infection Management and Prevention Service, Queensland Children's Hospital, Brisbane, Australia.
• ¹⁴ Child Health Research Centre, The University of Queensland, Brisbane, QLD, Australia.
• ¹⁵ School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
• ¹⁶ ICU and Jameson Trauma Institute, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
• ¹⁷ Nimes University Hospital, University of Montpellier, Nimes, France.
• ¹⁸ Central Microbiology, Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
• ¹⁹ Department of Pediatric and Neonatal Intensive Care, University Children's Hospital Zurich, Zurich, Switzerland.
• ²⁰ Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
• ²¹ Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
• ²² UQ Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia. a.irwin@uq.edu.au.
• ²³ Infection Management and Prevention Service, Queensland Children's Hospital, Brisbane, Australia. a.irwin@uq.edu.au.